In this Issue
Common Ground and Controversy
By Bart L. Dolmatch, MD
Ingemar A. Davidson, MD, PhD, discusses the differences in end-stage renal disease treatment around the globe and how practitioners can join forces to provide the best care possible.
Controversial studies lead to a national debate.
By Thomas M. Vesely, MD
Stent grafts have demonstrated superior patency rates compared to angioplasty for selected endovascular indications.
By Dheeraj Rajan, MD, FRCPC, FSIR
Peritoneal catheter use should be considered first for dialysis access.
By Jack Work, MD
The recent transition to clinical use of both allogeneic and autologous tissue-engineered vascular grafts represents a significant evolution in hemodialysis access.
By Todd N. McAllister, PhD; Sergio Garrido, MD; Jaime Velez, MD; Nicolas Chronos, MD; and Nicolas L’Heureux, PhD
An update on the evaluation of the Misago stent as part of the Harmonization By Doing regulatory collaboration between the United States and Japan.
By Srinivas Iyengar, MD, FACC
Early aggressive intervention for the treatment of acute ischemic stroke may limit subsequent disability.
By Marilyn M. Rymer, MD
CODING & REIMBURSEMENT
Examples of how to implement the updated codes for lower extremity revascularization procedures.
By Katharine L. Krol, MD, FSIR, FACR
A preview of today’s new products
A medical technology enthusiast and expert neurointerventionist discusses his interest in device development and what’s needed to find the Holy Grail of intracranial aneurysm treatment.